SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency.
Signal Transduct Target Ther
; 6(1): 151, 2021 04 10.
Article
in En
| MEDLINE
| ID: mdl-33839737
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Signal Transduct Target Ther
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: